Skip to content

validation of key genes associated with rebound pain after peripheral nerve block

validation of key genes associated with rebound pain after peripheral nerve block

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099214
Enrollment
Unknown
Registered
2025-03-19
Start date
2025-04-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rebound pain after peripheral nerve block

Interventions

Sponsors

Xiangyang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The orthopaedic patient with unilateral closed fracture of upper limb (humerus and below) in Xiangyang Central Hospital, aged 18-80years old, ASA I-III grade, who intend to undergo their first open reduction and internal fixation of unilateral fracture of upper limb (humerus and below) under brachial plexus block (intermuscular sulcus+axillary route).

Exclusion criteria

Exclusion criteria: 1. Patients undergoing combined surgeries at other sites. 2. Emergency patients; 3. Patients with peripheral neuropathy or preoperative nerve injury in the surgical limb; 4. Patients with a history of axillary surgery on the surgical side; 5. Patients with multiple surgeries (>1) on the surgical limb; 6. Patients with allergies to local anesthetics or contraindications to postoperative analgesics (e.g., NSAIDs and paracetamol); 7. Pregnant patients; 8. Patients with diabetes or vascular diseases; 9. Patients on long-term use of opioids, antipsychotics, or antidepressants; 10. Patients with infection at the injection site, acute porphyria, or kidney disease requiring dialysis; 11. Patients with contraindications to regional anesthesia, those requiring general anesthesia, or those with incomplete nerve block necessitating adjunctive general anesthesia or conversion to general anesthesia; 12. Patients with chronic pain syndromes; 13. Patients unable to comprehend perioperative questionnaires (due to language barriers or cognitive impairments); 14. Patients who have participated in similar studies within the past three months.

Design outcomes

Primary

MeasureTime frame
Expression levels of differential genes in peripheral blood of subjects and experimental animals before and after surgery.;NRS scores at 1,2 and 3 days after surgery(resting pain, average daily pain, most severe pain, and night pain scores);

Secondary

MeasureTime frame
anxiety scores at 1,2 and 3 days after surgery;quality of sleep day 1,2 and 3;dosage of postoperative analgesics(opiods, NSAIDS);duration of analgesia and motor block;NRS scores at 1,2 and 3 days after surgery(resting pain, average daily pain, most severe pain, and night pain scores);postoperative side effects(headache, dizziness, nausea, vomiting);

Countries

China

Contacts

Public ContactXingrui Gong

Xiangyang Central Hospital

40415311@qq.com+86 710 3522567

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026